Somatic mutations in chromatin remodeler genes could modify the epigenomic landscape of CLL, but they are uncommon in this malignancy in comparison with other lymphoid neoplasms. CHD2The scientific class of CLL is rather heterogeneous, starting from a fairly asymptomatic illness that may even regress spontaneously to some progressive ailment that e